Transcendent Capital Group’s Oracle ORCL Stock Holding History

Transcendent Capital Group’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,210	Closed	-$309K	–	108
2025 Q1	$309K	Buy	+2,210	New	+$360K	0.17%	72

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Transcendent Capital Group's ORCL Position: Q2 2025 in Review

Transcendent Capital Group sold out of Oracle (ORCL) in Q2 2025, closing a stake of 2,210 shares — an estimated $309K sold.

Transcendent Capital Group first reported a position in ORCL in Q1 2025 and held it in 1 quarter. The position peaked at $309K in Q1 2025. 3,616 funds tracked by Wall St. Rank hold ORCL as of Q2 2025.

Transcendent Capital Group reported no remaining Oracle position as of Q2 2025 after selling out during the quarter.
Transcendent Capital Group sold 2,210 Oracle shares in Q2 2025, an estimated $309K.
Transcendent Capital Group first reported a position in Oracle in Q1 2025 and held it in 1 quarter.
Transcendent Capital Group's Oracle position peaked at $309K in Q1 2025.
3,616 funds tracked by Wall St. Rank held Oracle as of Q2 2025.

Based on Transcendent Capital Group's 13F filing for Q2 2025, filed 25 Jul 2025.